Publications
Selected Scientific Publications
Farokhzad O, Cheng J, Teply B, Sherifi I, Jon S, Kantoff P, Richie J, and Langer, R. (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA, 103(16):6315-20.
Farokhzad O, Jon S, Khademhosseini A, Tran T, Lavan D, and Langer R. (2004) Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res, 64(21):7668-72.
Farokhzad O, Karp J, and Langer R. (2006) Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv, 3(3):311-24.
Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu F, Levy-Nissenbaum E, Radovic-Moreno A, Langer R, and Farokhzad O. (2007) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 28(5):869-76.
Zhang L, Radovic-Moreno A, Alexis F, Gu F, Basto P, Bagalkot V, Jon S, Langer R, Farokhzad O. (2007) Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem, 2(9):1268-71.
Bagalkot V, Farokhzad O, Langer R, and Jon S. (2006) An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl, 45(48):8149-52.
Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad O. (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Letters, electronic publication ahead of print.
|
